Lonodelestat
- Generic Name
- Lonodelestat
Clinical Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of POL6014 in Patients With CF
- First Posted Date
- 2018-11-20
- Last Posted Date
- 2021-09-28
- Lead Sponsor
- Santhera Pharmaceuticals
- Target Recruit Count
- 32
- Registration Number
- NCT03748199
- Locations
- 🇩🇪
Inamed GmbH, clinical unit, Gauting, Germany
🇩🇪Charité - Uniklinik Berlin, Klinik für Pädiatrie,Pneumologie, Immunologie, Erwachsenene-Mucoviszidose, Berlin, Germany
🇩🇪IKF Pneumologie GmbH & Co. KG, Institut für klinische Forschung Pneumologie, Frankfurt, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath